Akt and mTORC1 pathway activation is common in many human cancers, including ccRCC [18–22] and is mediated by phosphoinositide kinase 1 (PDK-1), the VHL/EGLN suppressive pathway [41], and the mTORC2 complex. This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.